世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15058
• 出版社/出版日：GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。PARP（ポリADPリボースポリメラーゼ）阻害剤の種類別市場規模（オラパリブ、タラゾパリブ）、用途別市場規模（卵巣がん、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・PARP（ポリADPリボースポリメラーゼ）阻害剤の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Pfizer、AstraZeneca、GlaxoSmithKline、Clovis Oncology、Everest Pharmaceuticals
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：オラパリブ、タラゾパリブ
・用途別分析2016年-2026年：卵巣がん、乳がん、その他
・PARP（ポリADPリボースポリメラーゼ）阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・PARP（ポリADPリボースポリメラーゼ）阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・PARP（ポリADPリボースポリメラーゼ）阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・PARP（ポリADPリボースポリメラーゼ）阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・PARP（ポリADPリボースポリメラーゼ）阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PARP (Poly ADP-ribose Polymerase) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global PARP (Poly ADP-ribose Polymerase) Inhibitors size is estimated to be USD 8773.2 million in 2026 from USD 2943.8 million in 2020, with a change XX% between 2020 and 2021. The global PARP (Poly ADP-ribose Polymerase) Inhibitors market size is expected to grow at a CAGR of 31.4% for the next five years.

Market segmentation
PARP (Poly ADP-ribose Polymerase) Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Olaparib
Talazoparib

Market segment by Application, can be divided into
Ovarian Cancer
Breast Cancer
Other

Market segment by players, this report covers
AbbVie
Pfizer
AstraZeneca
GlaxoSmithKline
Clovis Oncology
Everest Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of PARP (Poly ADP-ribose Polymerase) Inhibitors
1.2 Classification of PARP (Poly ADP-ribose Polymerase) Inhibitors by Type
1.2.1 Overview: Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type in 2020
1.2.3 Olaparib
1.2.4 Talazoparib
1.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market by Application
1.3.1 Overview: Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size & Forecast
1.5 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast by Region
1.5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region, (2016-2021)
1.5.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Prospect (2016-2026)
1.5.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Prospect (2016-2026)
1.5.6 South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
1.6.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
1.6.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Trends Analysis
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
2.1.4 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
2.2.4 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
2.3.4 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
2.4.4 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Clovis Oncology
2.5.1 Clovis Oncology Details
2.5.2 Clovis Oncology Major Business
2.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
2.5.4 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Clovis Oncology Recent Developments and Future Plans
2.6 Everest Pharmaceuticals
2.6.1 Everest Pharmaceuticals Details
2.6.2 Everest Pharmaceuticals Major Business
2.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
2.6.4 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Everest Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 PARP (Poly ADP-ribose Polymerase) Inhibitors Players Market Share
3.2.2 Top 10 PARP (Poly ADP-ribose Polymerase) Inhibitors Players Market Share
3.2.3 Market Competition Trend
3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Market Share by Type (2016-2021)
4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2016-2021)
5.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2026)
6.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2026)
6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
6.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2026)
6.3.2 United States PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
6.3.3 Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
6.3.4 Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2026)
7.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2026)
7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
7.3.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2026)
7.3.2 Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
7.3.3 France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
7.3.4 United Kingdom PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
7.3.5 Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
7.3.6 Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2026)
8.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2026)
8.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region
8.3.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Region (2016-2026)
8.3.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
8.3.3 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
8.3.4 South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
8.3.5 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
8.3.7 Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2026)
9.2 South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2026)
9.3 South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
9.3.1 South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2026)
9.3.2 Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
9.3.3 Argentina PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2026)
10.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2026)
10.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
10.3.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2026)
10.3.2 Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
10.3.4 UAE PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) by Region (2016-2021)
Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Region (2021-2026)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
Table 9. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
Table 13. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 15. AstraZeneca Major Business
Table 16. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
Table 17. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
Table 21. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Clovis Oncology Corporate Information, Head Office, and Major Competitors
Table 23. Clovis Oncology Major Business
Table 24. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
Table 25. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Everest Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. Everest Pharmaceuticals Major Business
Table 28. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product and Solutions
Table 29. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) by Players (2019-2021)
Table 31. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Players (2019-2021)
Table 32. Breakdown of PARP (Poly ADP-ribose Polymerase) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. PARP (Poly ADP-ribose Polymerase) Inhibitors Players Head Office, Products and Services Provided
Table 34. PARP (Poly ADP-ribose Polymerase) Inhibitors Mergers & Acquisitions in the Past Five Years
Table 35. PARP (Poly ADP-ribose Polymerase) Inhibitors New Entrants and Expansion Plans
Table 36. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) by Type (2016-2021)
Table 37. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Type (2016-2021)
Table 38. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Forecast by Type (2021-2026)
Table 39. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2021)
Table 40. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Forecast by Application (2021-2026)
Table 41. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 42. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 43. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 44. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 45. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 46. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 59. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 60. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 61. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 62. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 63. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 64. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. PARP (Poly ADP-ribose Polymerase) Inhibitors Picture
Figure 2. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type in 2020
Figure 3. Olaparib
Figure 4. Talazoparib
Figure 5. PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application in 2020
Figure 6. Ovarian Cancer Picture
Figure 7. Breast Cancer Picture
Figure 8. Other Picture
Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Region in 2020
Figure 13. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
Figure 19. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
Figure 20. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends
Figure 21. AbbVie Recent Developments and Future Plans
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Recent Developments and Future Plans
Figure 25. Clovis Oncology Recent Developments and Future Plans
Figure 26. Everest Pharmaceuticals Recent Developments and Future Plans
Figure 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Players in 2020
Figure 28. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share in 2020
Figure 30. Global Top 10 Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Type in 2020
Figure 33. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share Forecast by Type (2021-2026)
Figure 34. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application in 2020
Figure 35. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share Forecast by Application (2021-2026)
Figure 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Type (2016-2026)
Figure 37. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Application (2016-2026)
Figure 38. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 39. United States PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Type (2016-2026)
Figure 43. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Application (2016-2026)
Figure 44. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 45. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 53. China PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Type (2016-2026)
Figure 60. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Application (2016-2026)
Figure 61. South America PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 62. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 67. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source

PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT4897 2019年10月8日 136Pages
「PARP（ポリADP-リボースポリメラーゼ）阻害剤市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるPARP（ポリADP-リボースポリメラーゼ）阻害剤市場について調査・分析したレポートで、PARP（ポリADP-リボースポリメラーゼ）阻害剤の世界市場動向、市場規模、主要企業情...

世界のDNAポリメラーゼ市場 2021：企業別、地域別、種類・用途別

Global DNA Polymerase Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12223 2021年7月 104Pages
当調査資料では、DNAポリメラーゼのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。DNAポリメラーゼの種類別市場規模（原核生物DNAポリメラーゼ、真核生物DNAポリメラーゼ）、用途別市場規模（病院、バイオ製薬会社、学術研究機関、その他）、地域別市場...

世界のポリメラーゼ連鎖反応技術市場 2021：企業別、地域別、種類・用途別

Global Polymerase Chain Reaction Technology Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12593 2021年7月 105Pages
当調査資料では、ポリメラーゼ連鎖反応技術のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポリメラーゼ連鎖反応技術の種類別市場規模（デジタルポリメラーゼ連鎖反応、リアルタイムポリメラーゼ連鎖反応）、用途別市場規模（臨床用、研究用、その他）、地域別市場規模...

がん用CDK(サイクリン依存性キナーゼ)阻害剤市場：世界及び中国市場分析・予測（～2024年）

Cancer CDK Inhibitors Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT1158 2019年10月1日 143Pages
「がん用CDK(サイクリン依存性キナーゼ)阻害剤市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるがん用CDK(サイクリン依存性キナーゼ)阻害剤市場について調査・分析したレポートで、がん用CDK(サイクリン依存性キナーゼ)阻害剤の世界市場動向、市場規模、主要企業情報などが含ま...

ポリポリメラーゼ2市場：世界及び中国市場分析・予測（～2024年）

Poly Polymerase 2 Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT5143 2019年10月8日 136Pages
「ポリポリメラーゼ2市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるポリポリメラーゼ2市場について調査・分析したレポートで、ポリポリメラーゼ2の世界市場動向、市場規模、主要企業情報などが含まれています。ポリポリメラーゼ2のタイプ別には、BGB-290、AZ-0108、CK-...

世界のNSCLC用標的薬HER2阻害剤市場 2021：企業別、地域別、種類・用途別

Global Targeted Drug HER2 Inhibitors for NSCLC Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A11933 2021年7月 106Pages
当調査資料では、NSCLC用標的薬HER2阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。NSCLC用標的薬HER2阻害剤の種類別市場規模（アファチニブ、トラスツズマブ、その他）、用途別市場規模（NSCLC扁平上皮がん、NSCLC腺がん、NSCL...

世界のNSCLC用標的薬ROS1阻害剤市場 2021：企業別、地域別、種類・用途別

Global Targeted Drug ROS1 Inhibitors for NSCLC Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A11935 2021年7月 101Pages
当調査資料では、NSCLC用標的薬ROS1阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。NSCLC用標的薬ROS1阻害剤の種類別市場規模（クリゾチニブ、ロルラチニブ、エントレクチニブ、その他）、用途別市場規模（NSCLC扁平上皮がん、NSCLC...

世界のプロテインキナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別

Global Protein Kinase Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A03002 2021年7月 92Pages
当調査資料では、プロテインキナーゼ阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。プロテインキナーゼ阻害剤の種類別市場規模（Rx、OTC）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南ア...

世界の飼料用カビ防止剤市場 2021：企業別、地域別、種類・用途別

Global Mold Inhibitors for Feed Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A01972 2021年7月 101Pages
当調査資料では、飼料用カビ防止剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。飼料用カビ防止剤の種類別市場規模（プロピオン酸ベース、その他）、用途別市場規模（豚、家禽、牛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南...

世界の選択性Cox-2阻害剤市場 2021：企業別、地域別、種類・用途別

Global Selective Cox-2 Inhibitors Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A11883 2021年7月 141Pages
当調査資料では、選択性Cox-2阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。選択性Cox-2阻害剤の種類別市場規模（メロキシカム、セレコキシブ、エトリコキシブ、イムレコキシブ、エトドラク、パレコキシブ、その他）、用途別市場規模（関節リウマチ、...

PARP（ポリADP-リボースポリメラーゼ）阻害剤市場：世界及び中国市場分析・予測（～2024年） PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global PARP (Poly ADP-Ribose Polymerase) Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the mar…
ポリポリメラーゼ2市場：世界及び中国市場分析・予測（～2024年） Poly Polymerase 2 Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Poly Polymerase 2 industry with a focus on the Chinese market. The report provides key statistics on the market status of the Poly Polymerase 2 manufacturers an…
世界のDNAポリメラーゼ市場 2021：企業別、地域別、種類・用途別 The DNA Polymerase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
世界のポリメラーゼ連鎖反応技術市場 2021：企業別、地域別、種類・用途別 The Polymerase Chain Reaction Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
世界のDNAポリメラーゼ市場予測（～2024年） DNA polymerase is an enzyme that synthesizes DNA molecules from deoxyribonucleotides, the building blocks of DNA. These enzymes are essential for DNA replication and usually work in pairs to create two identical DNA strands from a single original DNA molecule. During this process, DNA polymerase "re…